A Randomized Comparison of Sirolimus- Versus Paclitaxel-Eluting Stent Implantation in Patients With Diabetes Mellitus. 2-Year Clinical Outcomes of the DES-DIABETES Trial

Journal of the American College of Cardiology

Volumn 53, Issue 9, 2009, Pages 812-813

  Lee, Seung Whan ^a   Park, Seong Wook ^a   Kim, Young Hak ^a   Yun, Sung Cheol ^a   Park, Duk Woo ^a   Lee, Cheol Whan ^a   Hong, Myeong Ki ^a   Rhee, Kyoung Suk ^a   Chae, Jei Keon ^a   Ko, Jae Ki ^a   Park, Jae Hyeong ^a   Lee, Jae Hwan ^a   Choi, Si Wan ^a   Jeong, Jin Ok ^a   Seong, In Whan ^a   Cho, Yoon Haeng ^a   Lee, Nae Hee ^a   Kim, June Hong ^a   Chun, Kook Jin ^a   Kim, Hyun Sook ^a   Park, Seung Jung ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; PACLITAXEL; RAPAMYCIN;

ADULT; ANGIOGRAPHY; BARE METAL STENT; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; FOLLOW UP; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; INCIDENCE; LETTER; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; REVASCULARIZATION; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; STENT; STENT THROMBOSIS;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CORONARY RESTENOSIS; DIABETES MELLITUS; DRUG-ELUTING STENTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PACLITAXEL; RISK FACTORS; SIROLIMUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 60449098323     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.11.028     Document Type: Letter

References (6)

1. Lee S.W., Park S.W., Kim Y.H., et al. A randomized comparison of sirolimus- versus paclitaxel-eluting stent implantation in patients with diabetes mellitus. J Am Coll Cardiol 52 (2008) 727-733
2. Daemen J., Garcia-Garcia H.M., Kukreja N., et al. The long-term value of sirolimus- and paclitaxel-eluting stents over bare metal stents in patients with diabetes mellitus. Eur Heart J 28 (2007) 26-32
3. Billinger M., Beutler J., Taghetchian K.R., et al. Two-year clinical outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents in diabetic patients. Eur Heart J 29 (2008) 718-725
4. Schömig A., Dibra A., Windecker S., et al. A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease. J Am Coll Cardiol 50 (2007) 1373-1380
5. Stettler C., Wandel S., Allemann S., et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 370 (2007) 937-948
6. Brar S.S., Kim J., Brar S.K., et al. Long-term outcomes by clopidogrel duration and stent type in a diabetic population with de novo coronary artery lesions. J Am Coll Cardiol 51 (2008) 2220-2227